Inventor
Anthony D. Piscopio
Inventor
Longmont, CO, US
Overview
Patents· 22 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds27%
A61KPreparations for medical, dental or toiletry purposes22%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations21%
C07CAcyclic or carbocyclic compounds17%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium5%
C07KPeptides4%
B41MPrinting, duplicating, marking, or copying processes1%
B44FSpecial designs or pictures1%
G09FDisplaying1%
Y10TTechnical subjects covered by former us classification1%
PatentTitleYear
11,053,284Process for the preparation of cyclic depsipeptides202110,689,419Process for the preparation of cyclic depsipeptides202010,508,122Heterocyclic hydroxamic acids as protein deacetylase inhibitors and dual protein deacetylase-protein kinase inhibitors and methods of use thereof2019RE047690Heterocyclic hydroxamic acids as protein deacetylase inhibitors and dual protein deacetylase-protein kinase inhibitors and methods of use thereof201910,100,089Process for the preparation of cyclic depsipeptides20189,840,520'Heterocyclic hydroxamic acids as protein deacetylase inhibitors and dual protein deacetylase-protein kinase inhibitors and methods of use thereof'20179,024,040'Processes for preparing benzimidazole compounds'20158,680,114'AKT protein kinase inhibitors'20148,501,956'Benzimidazole compounds'20138,383,832'Process for preparing benzimidazole compounds'20138,039,637'Process for preparing benzimidazole compounds'20116,509,337'Arylsulfonyl Hydroxamic Acid derivatives as MMP and TNF inhibitors'20036,462,238'Process for the reduction of cyano-substituted sulfones to aminoalkylene-substituted sulfones'20026,444,826'Processes and intermediates for preparing substituted chromanol derivatives'20026,355,825'Processes and intermediates for preparing substituted chromanol derivatives'20026,288,242'Processes and intermediates for preparing substituted chromanol derivatives'20016,133,286'Tetrahydronaphthalene and tetrahydroquinoline compounds, their preparation and their use as leukotriene B.sub.4 (LTB.sub.4) antagonists'20006,117,874'Benzopyran and benzo-fused compounds, their preparation and their use as leukotriene B.sub.4 (LTB.sub.4 ) antagonists'20006,096,906'Processes for preparing substituted chromanol derivatives'20006,051,601'Benzopyran and benzo-fused compounds, their preparation and their use as leukotriene B4 (LTB4) antagonists'20005,939,452'Benzopyran and benzo-fused compounds, their preparation and their use as leukotriene B4\' (LTB.sub.4) antagonists'19995,861,510'Arylsulfonyl hydroxamic acid derivatives as MMP and TNF inhibitors'1999Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1999–2003Patents assigned to PFIZER (10)· patent assignee history
1999–2021Based in Longmont, CO, US· patent location history
1999–2003Based in Longmount, CO, US· patent location history
2000Based in Groton, CT, US· patent location history
2002–2015Patents assigned to ARRAY BIOPHARMA INC (6)· patent assignee history
2011–2015Based in Boulder, CO, US· patent location history
2013–2015Patents assigned to DEMATTEI JOHN (3)· patent assignee history
2013–2015Patents assigned to EVANS MATTHEW CHARLES (3)· patent assignee history
2013–2015Patents assigned to FORD JAMES GAIR (3)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| PFIZER | 10 | 1999–2003 |
| ARRAY BIOPHARMA INC | 6 | 2002–2015 |
| DEMATTEI JOHN | 3 | 2013–2015 |
| EVANS MATTHEW CHARLES | 3 | 2013–2015 |
| FORD JAMES GAIR | 3 | 2013–2015 |
Locations
| Location | Patents | Span |
|---|---|---|
| Longmont, CO, US | 13 | 1999–2021 |
| Longmount, CO, US | 6 | 1999–2003 |
| Boulder, CO, US | 2 | 2011–2015 |
| Groton, CT, US | 1 | 2000 |